© 2020 MJH Life Sciences and OncLive. All rights reserved.
June 5th 2020, 9:06pm
Ronald Hoffman, MD, discusses the current polycythemia vera treatment paradigm.
June 3rd 2020, 1:02am
John P. Sfakianos, MD, discusses the utility of adjuvant therapy in bladder cancer management.
May 28th 2020, 1:15am
Joshua Brody, MD, discusses addressing required resistance to immunotherapy in non-Hodgkin lymphoma.
May 20th 2020, 1:58am
Adilia Hormigo, MD, PhD, discusses the impact of the coronavirus disease 2019 (COVID-19) on high density areas.
May 18th 2020, 5:38pm
John O. Mascarenhas, MD, discusses patient characteristics and outcomes following ruxolitinib discontinuation in myelofibrosis and research efforts being made to address a large unmet need in the space.
May 16th 2020, 1:17am
Che-Kai Tsao, MD, shares strategies to improve outcomes in renal cell carcinoma.
May 15th 2020, 9:24pm
May 13th 2020, 1:58am
John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.
May 12th 2020, 10:10pm
May 5th 2020, 11:04pm
William K. Oh, MD, discusses challenges with developing novel targeted agents in prostate cancer.